PDPL.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 aug 2023 @ 10:15):

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc...

Stats
Dagens volum	1 063.00
Gjennomsnittsvolum	0.00
Markedsverdi	101.08M
EPS	INR7.99 ( 2022-03-31 )
Last Dividend	INR1.125 ( 2010-09-13 )
Next Dividend	INR0 ( N/A )
P/E	-0.110
ATR14	INR0.0200 (0.69%)

Volum Korrelasjon

Lang: -0.05 (neutral)

Kort: 0.00 (neutral)

Signal:(33.266) Neutral

Parenteral Drugs (India) Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Parenteral Drugs (India) Korrelasjon - Valuta/Råvare

0.40
( neutral )

-0.50
( neutral )

0.00
( neutral )

-0.02
( neutral )

0.51
( weak )

-0.50
( neutral )

Parenteral Drugs (India) Økonomi

Annual	2022
Omsetning:	INR84.96M
Bruttogevinst:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2022
Omsetning:	INR84.96M
Bruttogevinst:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2021
Omsetning:	INR121.53M
Bruttogevinst:	INR48.37M (39.80 %)
EPS:	INR-40.82

FY	2020
Omsetning:	INR240.25M
Bruttogevinst:	INR13.40M (5.58 %)
EPS:	INR-38.26

Financial Reports:

No articles found.

Parenteral Drugs (India) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Parenteral Drugs (India) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0762 - No dividend growth expected in the near future

Information

First Dividend	INR1.125	2010-09-13
Last Dividend	INR1.125	2010-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.125	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0762
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.99	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.158	1.200	-5.26	-6.31	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0559	0.800	-4.72	-3.78	[1 - 3]
quickRatioTTM	0.00970	0.800	-4.65	-3.72	[0.8 - 2.5]
cashRatioTTM	0.0000001	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0.221	-1.500	6.31	-9.47	[0 - 0.6]
interestCoverageTTM	-0.000519	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0809	-0.162	[0 - 20]
debtEquityRatioTTM	-0.130	-1.500	-0.520	0.781	[0 - 2.5]
grossProfitMarginTTM	0.357	1.000	7.39	7.39	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00649	1.000	-2.13	-2.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00450	1.000	-1.136	-1.136	[0.2 - 2]
assetTurnoverTTM	0.0175	0.800	-3.22	-2.57	[0.5 - 2]
Total Score				-1.062

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.113	1.000	-0.112	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.162	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00111	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0568	1.000	-3.92	0	[0.1 - 0.5]
Total Score				0.0762

Parenteral Drugs (India)

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.